home / stock / cgtx / cgtx news

CGTX News and Press, Cognition Therapeutics Inc. From 09/06/22

Stock Information
Company Name: Cognition Therapeutics Inc.
Stock Symbol: CGTX
Market: NASDAQ
Website: cogrx.com
Menu
CGTX CGTX Quote CGTX Short CGTX News CGTX Articles CGTX Message Board
Get CGTX Alerts

News, Short Squeeze, Breakout and More Instantly...
CGTX - Cognition Therapeutics Announces Participation in September Investment Conferences

PURCHASE, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targe...
CGTX - Cognition Therapeutics GAAP EPS of -$0.25 beats by $0.07

Cognition Therapeutics press release ( NASDAQ: CGTX ): Q2 GAAP EPS of -$0.25 beats by $0.07 . Cash and cash equivalents on Q2 was approximately $45.8 million. For further details see: Cognition Therapeutics GAAP EPS of -$0.25 beats by $0.07

CGTX - Cognition Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Ongoing Patient Dosing in SHIMMER Study for DLB and SHINE Study for Alzheimer’s Disease Positive Preliminary Data for Dry AMD Program Presented at ARVO 2022 Proteomics Data from SPARC read out at AAIC PURCHASE, N.Y., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Cognition...

CGTX - Cognition Therapeutics wins $10M NIH grant to study lead asset in dementia

The National Institute of Health (NIH) awarded Cognition Therapeutics ( NASDAQ: CGTX ), a clinical-stage pharma focused on age-related degenerative diseases, more than $10M grant on Monday to further support a Phase 2 trial for the company's lead asset CT1812 in dementia. ...
CGTX - CinCor, Karuna top healthcare gainers; Reata, uniQure lead losers' pack

Gainers: CinCor Pharma CINC +66% . Karuna Therapeutics KRTX +61% . 23andMe ( ME ) +22% . Cerevel Therapeutics ( CERE ) +20% . Quoin Pharmaceuticals ( QNRX ) +16% . Losers: Reata Pharmaceuticals RETA -31% . uniQure QUR...

CGTX - BioNTech, Palantir Technologies, AMTD IDEA among premarket losers' pack

NuZee ( NUZE ) -24% on pricing $3.4M stock offering . Reata Pharmaceuticals ( RETA ) -20% on Q2 earnings release . Palantir Technologies ( PLTR ) -14% on Q2 earnings release . Digital World Acquisition ( DWACW ) -10% . Cognit...

CGTX - Allied Healthcare, Progyny top healthcare gainers; Quoin, Helius lead losers' pack

Gainers: Allied Healthcare Products ( AHPI ) +30% . Progyny ( PGNY ) +28% . Kazia Therapeutics ( KZIA ) +21% . Selecta Biosciences ( SELB ) +18% . Sensus Healthcare ( SRTS ) +17% . Losers: Quoin Pharmaceuticals ( QNRX...
CGTX - Cognition's Alzheimer's candidate demonstrates mechanism of action; shares soar

An analysis of biomarker data from Cognition Therapeutics' ( NASDAQ: CGTX ) Alzheimer's disease candidate CT1812 indicate the oral once-daily treatment supports a synaptoprotective mechanism of action and has a role in normalizing cellular processes. Proteomic analyses...

CGTX - Warner Bros. Discovery, Twilio, AMC Entertainment Holdings among premarket losers' pack

Hyzon Motors ( HYZN ) -36% after disclosing operational inefficiencies, financial issues . Helius Medical Technologies ( HSDT ) -30% . Quoin Pharmaceuticals ( QNRX ) -23% . Chembio Diagnostics ( CEMI ) -18% on Q2 earnings release . ...

CGTX - Cognition Therapeutics Presents New Proteomic Data on Effect of CT1812 Treatment on Normalization of Disrupted Alzheimer's Disease Processes

NEW YORK, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics , Inc. (NASDAQ: CGTX) announced that Mary Hamby, Ph.D. , vice president of research, presented results at the at Alzheimer’s Association International Conference (AAIC) of proteomic analysi...
Previous 10 Next 10